Guo Y - Search Results

1

[Retracted] MicroRNA‑199a‑3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1.

He Y, Yu X, Tang Y, Guo Y, Yuan J, Bai J, Yao T, Wu X. He Y, et al. Among authors: guo y. Mol Med Rep. 2023 Jan;27(1):5. doi: 10.3892/mmr.2022.12892. Epub 2022 Nov 11. Mol Med Rep. 2023. PMID: 36367157 Free PMC article.

2

MicroRNA‑199a‑3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1.

He Y, Yu X, Tang Y, Guo Y, Yuan J, Bai J, Yao T, Wu X. He Y, et al. Among authors: guo y. Mol Med Rep. 2021 Apr;23(4):237. doi: 10.3892/mmr.2021.11876. Epub 2021 Feb 4. Mol Med Rep. 2021. Retraction in: Mol Med Rep. 2023 Jan;27(1):5. doi: 10.3892/mmr.2022.12892 PMID: 33537822 Free PMC article. Retracted.

3

Retraction Note: MicroRNA-199a-5p suppresses the cell growth of colorectal cancer by targeting oncogene Caprin1.

Yu X, He Y, Wang Y, Tang Y, Guo Y, Yuan J, Bai J, Yao T, Wu X. Yu X, et al. Among authors: guo y. 3 Biotech. 2022 Nov;12(11):297. doi: 10.1007/s13205-022-03345-6. Epub 2022 Sep 29. 3 Biotech. 2022. PMID: 36276440 Free PMC article.

4

MicroRNA-199a-5p suppresses the cell growth of colorectal cancer by targeting oncogene Caprin1.

Yu X, He Y, Wang Y, Tang Y, Guo Y, Yuan J, Bai J, Yao T, Wu X. Yu X, et al. Among authors: guo y. 3 Biotech. 2020 Oct;10(10):453. doi: 10.1007/s13205-020-02433-9. Epub 2020 Sep 26. 3 Biotech. 2020. Retraction in: 3 Biotech. 2022 Nov;12(11):297. doi: 10.1007/s13205-022-03345-6 PMID: 33088650 Free PMC article. Retracted.

5

Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.

Zhao N, Guo Y, He Y, Chen Y, Xing J. Zhao N, et al. Among authors: guo y. J Clin Lab Anal. 2020 Aug;34(8):e23354. doi: 10.1002/jcla.23354. Epub 2020 May 17. J Clin Lab Anal. 2020. PMID: 32419232 Free PMC article.

6

MicroRNA‑126 protects SH‑SY5Y cells from ischemia/reperfusion injury‑induced apoptosis by inhibiting RAB3IP.

Sun Z, Zhao X, Zhang M, Li N, Zhao Y, Chen C, Li J, Guo Y, Feng Q. Sun Z, et al. Among authors: guo y. Mol Med Rep. 2022 Feb;25(2):62. doi: 10.3892/mmr.2021.12578. Epub 2021 Dec 22. Mol Med Rep. 2022. PMID: 34935056 Free PMC article.

7

Sirtuin 2 in Endometrial Cancer: A Potential Regulator for Cell Proliferation, Apoptosis and RAS/ERK Pathway.

Guo Y, Zhao N, Zhou J, Dong J, Wang X. Guo Y, et al. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980781. doi: 10.1177/1533033820980781. Technol Cancer Res Treat. 2020. PMID: 33327875 Free PMC article.

8

Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer.

Zhao N, Guo Y, Liu P, Chen Y, Wang Y. Zhao N, et al. Among authors: guo y. Arch Gynecol Obstet. 2022 Mar;305(3):693-701. doi: 10.1007/s00404-021-06216-2. Epub 2021 Sep 2. Arch Gynecol Obstet. 2022. PMID: 34476599

9

Higher Levels of Triglyceride, Fatty Acid Translocase, and Toll-Like Receptor 4 and Lower Level of HDL-C in Pregnant Women with GDM and Their Close Correlation with Neonatal Weight.

Zhou J, Bai J, Guo Y, Fu L, Xing J. Zhou J, et al. Among authors: guo y. Gynecol Obstet Invest. 2021;86(1-2):48-54. doi: 10.1159/000510032. Epub 2021 Jan 22. Gynecol Obstet Invest. 2021. PMID: 33486480

10

St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo.

Guo Y, Wang S, Liu Q, Dong Y, Liu Y. Guo Y, et al. PLoS One. 2024 Dec 27;19(12):e0316268. doi: 10.1371/journal.pone.0316268. eCollection 2024. PLoS One. 2024. PMID: 39729512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,663 results

Search Page

Filters